Flexion Therapeutics to Present at the 18th Annual Needham & Company Healthcare Conference
April 03 2019 - 4:30PM
Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that
Michael Clayman, M.D., President and Chief Executive Officer, will
participate in an analyst-led fireside chat at the 18th Annual
Needham & Company Healthcare Conference in New York City. The
fireside chat is scheduled to begin at 8:00 a.m. ET on Wednesday,
April 10, 2019. To access the live webcast and subsequent archived
recording of the presentation, please visit the Flexion website at
http://ir.flexiontherapeutics.com.
About Flexion Therapeutics Flexion
Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company
focused on the development and commercialization of novel, local
therapies for the treatment of patients with musculoskeletal
conditions, beginning with osteoarthritis, a type of degenerative
arthritis. The company's core values are focus, ingenuity,
tenacity, transparency and fun. For the past two years, Flexion has
been named one of the Best Places to Work by the Boston
Business Journal, and a Top Place to Work
in Massachusetts by The Boston Globe.
Contact:
Scott YoungVice President, Corporate Communications &
Investor RelationsFlexion Therapeutics, Inc.T:
781-305-7194syoung@flexiontherapeutics.com
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Apr 2023 to Apr 2024